hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06271863 id: Soh-Med-23-11-08MS briefTitle: Outcome of Conservative Management in Cases of Pre Mature Rupture of Membranes (PROM) Between 20 and 28 Weeks of Pregnancy in Sohag City Hospitals overallStatus: ENROLLING_BY_INVITATION date: 2023-06-01 date: 2024-06-01 date: 2024-07-01 date: 2024-02-22 date: 2024-02-22 name: Sohag University class: OTHER briefSummary: Prospective observational study conditions: PROM, Preterm (Pregnancy) studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: PROSPECTIVE count: 100 type: ESTIMATED measure: Conservation vs termination in cases of PROM 20 to 28 weeks of pregnancy sex: FEMALE minimumAge: 20 Years maximumAge: 40 Years stdAges: ADULT facility: Sohag university hospital city: Sohag country: Egypt lat: 26.55695 lon: 31.69478 hasResults: False
nctId: NCT06271850 id: P.T.REC/012/004949 briefTitle: Effect of Pilates Exercises on Forward Head Posture in Breastfeeding Women overallStatus: NOT_YET_RECRUITING date: 2024-02-20 date: 2024-06-20 date: 2024-07-20 date: 2024-02-22 date: 2024-02-23 name: Cairo University class: OTHER briefSummary: Musculoskeletal postural issues stemming from infant care positions can exert a significant impact on the cervical, thoracic, and lumbar spine. These positions can induce mechanical alterations in the spine's natural curvature, potentially resulting in long-term deformities in postnatal women such as forward head posture (FHP), ultimately contributing to physical disability over the long term.so, The purpose of this study is to determine the effect of Pilates exercises on FHP in breastfeeding women. conditions: Breastfeeding studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: Ergonomics breastfeeding training name: Pilates exercises measure: Measurement of craniovertebral angle (CVA) measure: Assessment of neck pain intensity measure: Measurement of cervical range of motion measure: Evaluation of disability due to neck pain measure: Assessment of neck muscle fatigue measure: Assessment of breastfeeding self-efficacy measure: Measurement of weight and height of baby measure: Assessment of Health-Related Quality of Life sex: FEMALE minimumAge: 20 Years maximumAge: 35 Years stdAges: ADULT hasResults: False
nctId: NCT06271824 id: 23-1519 briefTitle: Self-Compassion to Enhance the Well-Being of Caregivers of Children With Physical Disabilities overallStatus: RECRUITING date: 2024-03-21 date: 2024-06 date: 2024-06 date: 2024-02-22 date: 2024-03-26 name: University of North Carolina, Chapel Hill class: OTHER briefSummary: The goal of this clinical trial is to test the feasibility, acceptability and preliminary social/emotional well-being outcomes of a tailored, online self-compassion-based resilience course for caregivers of children with physical disabilities. The main questions it aims to answer are:
Participants will complete a screening, a verbal consent process and an electronic pre-course survey. Then, they will participate in a 6-session weekly online course with other caregivers and led by a certified Mindful Self-Compassion instructor. The course has been created with feedback from caregivers and includes skills for recognizing and coping with difficult emotions while connecting with others who have similar caregiving experiences. After the course, participants will repeat the electronic survey and will provide feedback on the course during a live, online feedback session. conditions: Stress conditions: Caregiver Burden conditions: Anxiety conditions: Depressive Symptoms studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 12 type: ESTIMATED name: Self-Compassion Based Resilient Caregiving Course measure: Percentage of participants who withdraw from course measure: Percentage of participants who attend at least 4 of 6 intervention sessions measure: Percentage of participants who rate the course as "acceptable" or "completely acceptable" measure: Percentage of intervention topics covered measure: Mean Change in Perceived Stress as Measured by the Perceived Stress Scale (PSS-10 item) at 6 weeks measure: Mean Change in Resilience as measured by the Connor-Davidson Resilience Scale-10 at 6 weeks measure: Mean Change in Anxiety as measured by the PROMIS-SF 7-item Anxiety Scale at 6 weeks measure: Mean Change in Depressive symptoms as measured by the PROMIS-SF 8-item Depression Scale at 6 weeks measure: Mean Change in Self-Compassion as measured by the Self-Compassion Scale-Short form (SCS-SF) at 6 weeks measure: Mean Change in Caregiver Burden as measured by the 12-item Zarit Caregiver Burden Scale (ZBI-12) at 6 weeks measure: Mean Change in Caregiver Uplifts as measured by the Uplifts subscale of the Revised Burden Measure at 6 weeks measure: Mean Change in Difficulties with Emotion Regulation as measured by the Difficulties in Emotion Regulation-Short Form Scale sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of North Carolina at Chapel Hill status: RECRUITING city: Chapel Hill state: North Carolina zip: 27599 country: United States name: Monica Coudurier role: CONTACT email: m_coudurier@unc.edu lat: 35.9132 lon: -79.05584 hasResults: False
nctId: NCT06271811 id: UJAPFPS briefTitle: Flossing Band Integration in Conventional Physiotherapy for Patellofemoral Pain Syndrome acronym: flossing overallStatus: COMPLETED date: 2023-01-09 date: 2023-11-14 date: 2023-11-20 date: 2024-02-22 date: 2024-02-23 name: University of Jaén class: OTHER name: University of Jaen briefSummary: The goal of this clinical trial is to assess the efficacy of adding flossing band therapy to conventional physiotherapy in patients diagnosed with Patellofemoral Pain Syndrome (PFPS). The main questions it aims to answer are:
* What are the effects of flossing band therapy on knee functionality and muscle strength in PFPS patients? Participants will be randomly assigned to either the Standard Physiotherapy group or the Flossing Band and Physiotherapy group. In addition to conventional physiotherapy, participants in the Flossing Band group will undergo sessions where a flossing band is applied around the knee joint to provide moderate compression. Researchers will compare the two groups to determine if the addition of flossing band therapy enhances treatment outcomes for PFPS. conditions: Anterior Knee Pain Syndrome conditions: Patellofemoral Pain Syndrome studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 50 type: ACTUAL name: Flossing band name: Conventional physiotherapy measure: Disability related to patellofemoral pain measure: Knee extensor muscle strength measure: Pain report measure: Self-reported function measure: Short Form-36 (SF-36) measure: Berg Balance Scale (BBS) measure: Pittsburgh Sleep Quality Index measure: Brief Pain Questionnaire measure: Perceived Stress Scale sex: ALL minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: University of Jaen city: Jaen zip: 23009 country: Spain lat: 37.76922 lon: -3.79028 hasResults: False
nctId: NCT06271798 id: P.T.REC/012/004867 briefTitle: Effect Of Resistive Exercises Versus Aerobic Exercises On Varicose Veins In Postmenopausal Women overallStatus: RECRUITING date: 2024-02-20 date: 2024-04-05 date: 2024-04-19 date: 2024-02-22 date: 2024-03-05 name: Cairo University class: OTHER briefSummary: The purpose of this study will be to determine the effect of resistive exercises on varicose veins in postmenopausal women, the effect of aerobic exercise on varicose veins in postmenopausal women and to compare between the effect of resistive exercise versus aerobic exercise on varicose veins in post menopausal women. conditions: Varicose Veins studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 44 type: ESTIMATED name: Life style modification advice name: Resistive exercise name: Aerobic exercises measure: Peak popliteal vein velocity measure: Visual analogue scale measure: Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) measure: 6-minute. walk test sex: FEMALE minimumAge: 50 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Cairo University status: RECRUITING city: Giza country: Egypt name: Mai Saif Elnasr Ghietah, M.Sc. Stud role: CONTACT name: Mai Mohamed Ali, PhD role: CONTACT name: Soheir Mahmoud Elkosery, PhD role: PRINCIPAL_INVESTIGATOR name: Hossam Aldin H. Kamel, PhD role: PRINCIPAL_INVESTIGATOR lat: 30.00808 lon: 31.21093 hasResults: False
nctId: NCT06271785 id: 49RC22_0354 briefTitle: Prognostic Value of High-resolution Electrical Source Imaging on the Success of Pediatric Focal Epilepsy Surgery acronym: ISEPEE overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2026-10-01 date: 2026-10-01 date: 2024-02-22 date: 2024-03-12 name: University Hospital, Angers class: OTHER_GOV briefSummary: This study investigates the usefulness of high resolution electrical source imaging (HR-ESI) in the setting of presurgical evaluation of drug-resistant focal epilepsy in children.
Among the secondary objectives, the investigators will address methodological issues related to the resolution of the inverse problem (methods using distributed sources models versus methods based on equivalent dipole estimation), the potential added value to model high-frequency oscillations (HFO), and the investigators will assess the cost-utility of the HR-ESI procedure. conditions: Epilepsy in Children studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 120 type: ESTIMATED name: HR-EEG recording measure: Prediction accuracy index measure: Localization of the epileptogenic zone (Baseline) measure: Localization of the epileptogenic zone (After Surgery) measure: preoperative accuracy of epileptogenic source localization measure: prognostic value of HFO measure: Impact of method of sources reconstruction, conditions of EEG recordings and sampling rate measure: health-economic modeling sex: ALL minimumAge: 2 Years maximumAge: 17 Years stdAges: CHILD facility: Angers university hospital, Pédiatric department city: Angers zip: 49000 country: France name: Patrick Van Bogaert, Professor role: CONTACT phone: 02 41 35 48 46 email: Patrick.VanBogaert@chu-angers.fr lat: 47.46667 lon: -0.55 facility: Lille University Hospital, Clinical Neurophysiology Department city: Lille zip: 59000 country: France name: Philippe DERAMBURE, Professor role: CONTACT phone: 03 20 44 63 62 email: Philippe.DERAMBURE@CHRU-LILLE.FR lat: 50.63297 lon: 3.05858 facility: Civil Hospices of Lyon, Functional Neurology Department city: Lyon zip: 69677 country: France name: Julien Jung, Doctor role: CONTACT phone: 04 72 35 79 00 email: julien.jung@chu-lyon.fr lat: 45.74848 lon: 4.84669 facility: Marseille Timone University Hospital, Epileptology and Cerebral Rhythmology Department city: Marseille zip: 13000 country: France name: Fabrice BARTOLOMEI, Professor role: CONTACT phone: 04 91 38 46 84 email: Fabrice.BARTOLOMEI@ap-hm.fr lat: 43.29551 lon: 5.38958 facility: Nancy University Hospital, Neurology Department city: Nancy zip: 54000 country: France name: Louis Maillard, Professor role: CONTACT phone: 03 83 85 16 09 email: l.maillard@chru-nancy.fr lat: 48.68439 lon: 6.18496 facility: Paris Neck University Hospital city: Paris zip: 75015 country: France lat: 48.85341 lon: 2.3488 facility: Paris Robert-Debré University Hospital, Department of Physiology, Pediatric functional explorations city: Paris zip: 75019 country: France name: François-Xavier MAUVAIS, Doctor role: CONTACT phone: 01 40 03 20 00 email: francois-xavier.mauvais@aphp.fr lat: 48.85341 lon: 2.3488 facility: Rothschild Ophtalmologic Fondation, Pediatric neurosurgery Department city: Paris zip: 75019 country: France name: Emmanuel Raffo, Professor role: CONTACT phone: 01 48 03 68 17 email: eraffo@for.paris lat: 48.85341 lon: 2.3488 facility: Rennes University Hospital, Pediatric department city: Rennes zip: 35000 country: France name: Silvia Adriana NAPURI PEIRANO, Doctor role: CONTACT phone: 02 99 26 58 34 email: Silviaadriana.NAPURI.PEIRANO@chu-rennes.fr lat: 48.11198 lon: -1.67429 hasResults: False
nctId: NCT06271772 id: 18-26045-RII briefTitle: Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II acronym: REAGIR II overallStatus: NOT_YET_RECRUITING date: 2024-04-30 date: 2024-12-31 date: 2025-07-31 date: 2024-02-22 date: 2024-02-22 name: University of California, San Francisco class: OTHER name: Stanford University name: Aravind Eye Care System name: Federal University of São Paulo briefSummary: Rose Bengal Electromagnetic Activation with Green light for Infection Reduction II (REAGIR II) is a randomized, double-masked feasibility study. The purpose of this study is to determine differences in 6-month visual acuity between medical antimicrobial treatments alone versus antimicrobial treatment plus cross-linking with rose Bengal (RB-PDT).
Patients presenting to one of the Aravind Eye Hospitals in India or to the Federal University of São Paulo ophthalmology clinic in Brazil with smear-positive and/or culture positive typical (I.e. non-Nocardia or Mycobacteria) bacterial corneal ulcers and moderate to severe vision loss, defined as Snellen visual acuity of 20/40 of worse, will be eligible for inclusion. Those who agree to participate will be randomized to one of two treatment groups:
* Group 7, Sham RB-PDT Plus Early Steroids: topical 0.5% moxifloxacin plus topical difluprednate 0.05% plus sham RB-PDT conditions: Bacterial Keratitis studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: Difluprednate Ophthalmic name: Rose Bengal name: Moxifloxacin Ophthalmic measure: Best Spectacle-Corrected Visual Acuity measure: Best Spectacle-Corrected Visual Acuity measure: Scar size measure: Scar depth measure: Adverse Events sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Federal University of São Paulo city: São Paulo country: Brazil name: Ana Luisa Hofling Lima, MD, PhD role: CONTACT email: analhofling@gmail.com lat: -23.5475 lon: -46.63611 facility: Aravind Eye Care System city: Madurai state: Tamil Nadu country: India name: N V Prajna role: CONTACT email: prajna@aravind.org lat: 9.91769 lon: 78.11898 hasResults: False
nctId: NCT06271759 id: PSYFRAG briefTitle: Psychological Effects of a Set of Functional Fragrances acronym: PSYFRAG overallStatus: RECRUITING date: 2024-03-15 date: 2024-08-15 date: 2024-08-15 date: 2024-02-22 date: 2024-04-09 name: University of Bucharest class: OTHER name: IFF (International Flavors & Fragrances) briefSummary: The goal of this clinical trial is to test the effectiveness of an intervention designed to improve wellness through aromatherapy. The main question it aims to answer is whether this intervention can deliver beneficial psychological effects on stress, anxiety and mood, as well as overall well-being.
Participants will receive a bottle with a no/neutral odor or an essential oil (or a blend of essential oils) for home administration and will be asked to complete a series of scales pre and post self-administration twice one week apart. conditions: Stress conditions: Anxiety conditions: Well-Being, Psychological conditions: Mood studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: BASIC_SCIENCE masking: SINGLE whoMasked: PARTICIPANT count: 80 type: ESTIMATED name: Fragrance inhalation measure: Affective states - relaxation measure: Affective states - contentment measure: Affective states - happiness measure: Affective states - stress measure: Affective states - motivation measure: Affective states - tension measure: Emotional changes measure: General mental health - Depression measure: General mental health - Anxiety measure: General mental health - Stress sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Bucharest status: RECRUITING city: Bucharest zip: 050663 country: Romania name: Cezar Giosan, PhD role: CONTACT phone: +40730908050 email: giosan@outlook.com lat: 44.43225 lon: 26.10626 hasResults: False
nctId: NCT06271746 id: TCH101 briefTitle: Treatment of Fibromyalgia With the FibroNova Neuromodulation Device overallStatus: RECRUITING date: 2024-03-04 date: 2025-03-01 date: 2025-06-01 date: 2024-02-22 date: 2024-04-11 name: Theranica class: INDUSTRY briefSummary: Fibromyalgia (FM) is a chronic disorder that affects the musculoskeletal system, causing widespread pain, tenderness, and fatigue. It is estimated to affect 1-5% of the population. The primary symptom of fibromyalgia is widespread pain throughout the body, accompanied by tenderness and sensitivity to pressure.
The current study examines the safety and efficacy of REN technology, implemented via the FibroNova device for treating fibromyalgia pain and related symptoms. conditions: Fibromyalgia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Parallel Assignment. Randomized, double-blind, sham-controlled primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR count: 170 type: ESTIMATED name: FibroNova (Active mode) name: FibroNova (Sham mode) measure: Mean reduction in pain level during the last 14 days of the treatment phase (weeks 15 through 16) compare to the last 14 days of baseline phase (weeks 3 through 4) measure: Device safety (rate of adverse events and device related adverse events) measure: Mean change in the Revised Fibromyalgia Impact Questionnaire FIQR total score measure: Mean change in FIQR functionality sub-scale score measure: Mean change in FIQR pain item score measure: Mean change in Brief Pain Inventory (BPI) score measure: Improvement in patient global impression according to PGIC score measure: Mean reduction in functional disability during the last 14 days of the treatment phase (weeks 15 through 16) compare to the last 14 days of baseline phase (weeks 3 through 4) measure: Improvement in quality of life measure: Improvement in sleep quality measure: Mean change in level of depression measure: Mean change in level of anxiety measure: Mean change in level of cognitive impairment measure: Mean change in level of cognitive presenteeism measure: Mean reduction of at least 30% in pain level measure: Rate of treatment tolerability measure: User experience measure: Patient Global Impression- change (PGI-C measure: Patient Global Impression- change (PGI-C)- mid study: sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Clinical Research Professionals status: RECRUITING city: Chesterfield state: Missouri zip: 63005 country: United States name: Shahmir Kahn role: CONTACT phone: 636-220-1200 email: skhan@clinicalresearchprofessionals.net name: Daniel Mattson, MD role: PRINCIPAL_INVESTIGATOR lat: 38.66311 lon: -90.57707 facility: ClinVest Headlands Research status: RECRUITING city: Springfield state: Missouri zip: 65807 country: United States name: Brittni kendrick role: CONTACT phone: 417-883-7889 email: brittni.kendrick@clinvest.com name: David True, MD role: PRINCIPAL_INVESTIGATOR lat: 37.21533 lon: -93.29824 facility: Gershon Pain Specialists status: RECRUITING city: Virginia Beach state: Virginia zip: 23454 country: United States name: Erika Dorman role: CONTACT phone: 757-496-2050 email: edorrman@gershonpain.com name: Steven Gershon, MD role: PRINCIPAL_INVESTIGATOR lat: 36.85293 lon: -75.97799 facility: Tel Aviv Sourasky Medical Center status: NOT_YET_RECRUITING city: Tel Aviv zip: 6423906 country: Israel name: Sara Pel role: CONTACT phone: +972-52-4266605 email: sarap@tlvmc.gov.ii name: Ori Elkayam, MD role: PRINCIPAL_INVESTIGATOR lat: 32.08088 lon: 34.78057 hasResults: False
nctId: NCT06271733 id: 21110503 briefTitle: TMS for Veterans Attending a 2-week Intensive Outpatient Program for PTSD overallStatus: ENROLLING_BY_INVITATION date: 2022-01-11 date: 2026-01-31 date: 2027-01-31 date: 2024-02-22 date: 2024-02-29 name: Rush University Medical Center class: OTHER briefSummary: The goal of this study is to determine whether complementing regular intensive PTSD treatment with intermittent theta burst stimulation (iTBS) applied to the right dorsolateral prefrontal cortex (DLPFC) can improve treatment response for individuals attending a 2-week intensive outpatient program (IOP) for PTSD. Specifically, the present study will compare iTBS versus a sham condition during the second week of the 2- week IOP for veterans who have not experienced PTSD symptom reductions over the course of the first week of the Road Home Program intensive PTSD treatment program. conditions: PTSD studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 30 type: ESTIMATED name: TMS name: Sham measure: PTSD Checklist for DSM-5 (PCL-5) measure: Patient Health Questionnaire-9 (PHQ-9) sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Rush University Medical Center city: Chicago state: Illinois zip: 60612 country: United States lat: 41.85003 lon: -87.65005 hasResults: False
nctId: NCT06271720 id: faculty of physical therapy briefTitle: Impact of Visceral Manipulation Versus Integrated Neuromuscular Inhibition Technique in Shoulder Impingement Syndrome overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-05 date: 2024-05 date: 2024-02-22 date: 2024-02-22 name: Noha Elserty class: OTHER briefSummary: This study will be conducted To evaluate the effect of Visceral Manipulation versus Integrated Neuromuscular Inhibition Technique on the upper fiber of trapezius on pain intensity, pain threshold, shoulder range of motion, and function in shoulder impingement syndrome conditions: Shoulder Impingement studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 75 type: ESTIMATED name: visceral manipulation name: integrated neuromuscular inhibition measure: pain intensity measure: pain pressure threshold measure: shoulder range of motion measure: shoulder functional level sex: ALL minimumAge: 20 Years maximumAge: 40 Years stdAges: ADULT hasResults: False
nctId: NCT06271707 id: ANES-2024-32720 briefTitle: Stellate Ganglion Block overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2026-06-30 date: 2026-09-30 date: 2024-02-22 date: 2024-04-23 name: University of Minnesota class: OTHER briefSummary: The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care. conditions: Esophagectomy conditions: Pneumonectomy conditions: Lobectomy studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: TRIPLE maskingDescription: This is a double blind randomized prospective controlled trial. Randomization will be 1:1. whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 48 type: ESTIMATED name: 0.5% bupivacaine name: Saline measure: an ultrasound guided left stellate ganglion block with 5 mL of saline. measure: Atrial fibrillation; Other arrhythmias; Adverse events. sex: ALL minimumAge: 18 Years maximumAge: 85 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False